Capsule Summary Slidesets

Share

Program Content

Activities

  • Upadacitinib MoA in RA
    SELECT-NEXT and SELECT-BEYOND: Proteonomic Analysis of Upadacitinib Mode of Action in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2019

    Expires: November 11, 2020

  • SELECT Analysis of MACE/VTE
    SELECT Pooled Analysis: MACE and VTE Across Upadacitinib Studies in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2019

    Expires: November 12, 2020

  • Ultralow-Dose Rituximab
    REDO: Ultra-Low-Dose Rituximab for Continued Treatment of RA in Patients on Stable Treatment With Rituximab
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2019

    Expires: November 13, 2020

  • TARA: Tapering DMARDs vs TNF Inhibitors
    TARA: Tapering csDMARDs First vs TNF Inhibitors in Patients With RA and Very Low Disease Activity
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2019

    Expires: November 13, 2020

  • VNS Pilot Study
    Pilot Study of Neurostimulation Using a Novel VNS Device for Treatment of Drug-Refractory RA
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 15, 2019

    Expires: November 13, 2020

  • JAK Inhibitor Meta-analysis of MACE/VTE
    Meta-analysis: MACE and VTE Across JAK Inhibitor Studies in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 18, 2019

    Expires: November 16, 2020

  • MACE With HCQ
    Impact of Hydroxychloroquine on MACE in Medicare Recipients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 18, 2019

    Expires: November 16, 2020

  • Pooled FIL Safety
    Filgotinib Demonstrates Favorable Safety in Pooled Analysis of Phase III Studies in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 18, 2019

    Expires: November 16, 2020

  • Phase IIb PF-06650833
    Phase IIb Trial of IRAK4 Inhibitor, PF-06650833, in Patients With Moderately to Severely Active RA and Inadequate Response to MTX
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 18, 2019

    Expires: November 16, 2020

  • Baricitinib Safety
    All-BARI-RA Updated Findings: Long-term Safety of Baricitinib in Patients With Rheumatoid Arthritis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 25, 2019

    Expires: November 23, 2020

Provided by

ProCE Banner

Supporters

Gilead

Mallinckrodt Pharmaceuticals